Cellosaurus HepaRG-CAR (CVCL_XI49)
Cell line name | HepaRG-CAR |
---|---|
Accession | CVCL_XI49 |
Resource Identification Initiative | To cite this cell line use: HepaRG-CAR (RRID:CVCL_XI49) |
Comments | Group: Patented cell line. Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3291. Characteristics: Compared to the parent cell line, has improved liver functionality. Drug metabolism is highly improved. Culturing can be performed in serum-free conditions both in the presence or absence of DMSO. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
Disease | Hepatitis C infection (NCIt: C3098) Hepatocellular carcinoma (NCIt: C3099) Hepatocellular carcinoma (ORDO: Orphanet_88673) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_9720 (HepaRG) |
Sex of cell | Female |
Age at sampling | Age unspecified |
Category | Cancer cell line |
Publications | PubMed=27780834; DOI=10.1124/dmd.116.072603 Patent=US20190256822 PubMed=32130581; DOI=10.1007/s10616-020-00384-w; PMCID=PMC7225227 |
Cross-references | |
Encyclopedic resources | Wikidata; Q94103091 |
Entry history | |
Entry creation | 19-Dec-2019 |
Last entry update | 19-Dec-2024 |
Version number | 11 |